These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 24815486)
1. Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma. Wu SY; Yu MX; Li XG; Xu SF; Shen J; Sun Z; Zhou X; Chen XZ; Tu JC Asian Pac J Cancer Prev; 2014; 15(7):3299-304. PubMed ID: 24815486 [TBL] [Abstract][Full Text] [Related]
2. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection. Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199 [TBL] [Abstract][Full Text] [Related]
3. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma. Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137 [TBL] [Abstract][Full Text] [Related]
4. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery. Shi RY; Yang XR; Shen QJ; Yang LX; Xu Y; Qiu SJ; Sun YF; Zhang X; Wang Z; Zhu K; Qin WX; Tang ZY; Fan J; Zhou J Cancer; 2013 Mar; 119(5):993-1003. PubMed ID: 23132676 [TBL] [Abstract][Full Text] [Related]
5. Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis. Chen Y; Hong Z; Lu S; Zhang N; Rong G; Chang X; Liu Z; Bai W; Dong Z; Gao X; Zeng Z; Lu Y Med Sci Monit; 2018 Nov; 24():7875-7882. PubMed ID: 30390420 [TBL] [Abstract][Full Text] [Related]
6. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma. Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431 [TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma. Xu Y; Zhu M; Zhang S; Liu H; Li T; Qin C Pathol Oncol Res; 2010 Jun; 16(2):169-75. PubMed ID: 19757198 [TBL] [Abstract][Full Text] [Related]
8. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma. Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728 [TBL] [Abstract][Full Text] [Related]
9. Osteopontin promoter polymorphisms at locus -443 are associated with metastasis and poor prognosis of human intrahepatic cholangiocarcinoma in Chinese population. Zhao XQ; Ma HX; Su MS; He L Int J Clin Exp Pathol; 2014; 7(10):6914-21. PubMed ID: 25400775 [TBL] [Abstract][Full Text] [Related]
10. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932 [TBL] [Abstract][Full Text] [Related]
11. High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study. Bi C; Liu M; Rong W; Wu F; Zhang Y; Lin S; Liu Y; Wu J; Wang L BMC Cancer; 2019 Mar; 19(1):213. PubMed ID: 30849962 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma. Zhang C; Bai DS; Huang XY; Shi GM; Ke AW; Yang LX; Yang XR; Zhou J; Fan J PLoS One; 2013; 8(1):e54619. PubMed ID: 23349941 [TBL] [Abstract][Full Text] [Related]
14. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome. Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis. Huang Q; Liu L; Liu CH; You H; Shao F; Xie F; Lin XS; Hu SY; Zhang CH Asian Pac J Cancer Prev; 2013; 14(2):829-34. PubMed ID: 23621247 [TBL] [Abstract][Full Text] [Related]
16. Up-regulation of 14-3-3ΞΆ expression in intrahepatic cholangiocarcinoma and its clinical implications. Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422 [TBL] [Abstract][Full Text] [Related]
17. Expression of GLP-1R protein and its clinical role in intrahepatic cholangiocarcinoma tissues. Chen BD; Zhao WC; Dong JD; Sima H Mol Biol Rep; 2014 Jul; 41(7):4313-20. PubMed ID: 24577752 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma. Li SQ; Liang LJ; Hua YP; Peng BG; He Q; Lu MD; Chen D Chin Med J (Engl); 2009 Oct; 122(19):2286-91. PubMed ID: 20079127 [TBL] [Abstract][Full Text] [Related]
19. Elevated expression of G Cao XY; Ji HJ; Zhou YJ; Lu XF; Shen JY; Wu ZR; Bu H; Shi YJ Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):638-644. PubMed ID: 29291784 [TBL] [Abstract][Full Text] [Related]
20. Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinoma. Dong ZR; Zhang C; Cai JB; Zhang PF; Shi GM; Gao DM; Sun HC; Qiu SJ; Zhou J; Ke AW; Fan J Tumour Biol; 2015 Apr; 36(4):2763-71. PubMed ID: 25480415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]